Literature DB >> 15024051

Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha.

Cheol Yi Hong1, Jin Hee Park, Ryun Seop Ahn, Suhn Young Im, Hueng-Sik Choi, Jaemog Soh, Synthia H Mellon, Keesook Lee.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) has been demonstrated to inhibit steroidogenesis in Leydig cells at the transcriptional level of steroidogenic enzymes. However, the molecular mechanism of this observed gene repression is not well understood. We now demonstrate that nuclear factor kappaB (NF-kappaB) activated by TNF-alpha inhibits the transactivation of orphan nuclear receptors, which regulate the expression of steroidogenic-enzyme genes. TNF-alpha treatment suppressed the luteinizing-hormone-induced or Nur77/SF-1-stimulated promoter activity of steroidogenic-enzyme genes in Leydig cells. The TNF-alpha-mediated gene suppression was blocked by treatment with an inhibitor of NF-kappaB. In addition, overexpression of the p65 (RelA) subunit of NF-kappaB showed the same effect as TNF-alpha and inhibited Nur77 transactivation, suggesting the involvement of NF-kappaB activation in the observed gene repression. Physical association of Nur77 with p65 was revealed by mammalian two-hybrid, GST pull-down, and coimmunoprecipitation analyses. The NF-kappaB inhibition of Nur77 transactivation was likely due to the competition of p65 for Nur77 binding with coactivators. Finally, chromatin immunoprecipitation assays revealed that TNF-alpha treatment caused the recruitment of NF-kappaB to the promoter of the steroidogenic-enzyme p450c17 gene, supporting the hypothesis that the TNF-alpha-mediated gene repression involves NF-kappaB inhibition of the transcriptional activity of Nur77 and other orphan nuclear receptors. These findings provide a molecular mechanism underlying the inhibition of testicular steroidogenesis by proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024051      PMCID: PMC371106          DOI: 10.1128/MCB.24.7.2593-2604.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

Review 1.  Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways.

Authors:  L I McKay; J A Cidlowski
Journal:  Endocr Rev       Date:  1999-08       Impact factor: 19.871

2.  Retinoic acids up-regulate steroidogenic acute regulatory protein gene.

Authors:  H K Lee; M S Yoo; H S Choi; H B Kwon; J Soh
Journal:  Mol Cell Endocrinol       Date:  1999-02-25       Impact factor: 4.102

3.  Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations.

Authors:  S Y Na; S K Lee; S J Han; H S Choi; S Y Im; J W Lee
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

4.  The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.

Authors:  R Dechend; F Hirano; K Lehmann; V Heissmeyer; S Ansieau; F G Wulczyn; C Scheidereit; A Leutz
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

5.  Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.

Authors:  S Y Na; B Y Kang; S W Chung; S J Han; X Ma; G Trinchieri; S Y Im; J W Lee; T S Kim
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

6.  Fibronectin binding promotes a PKC-dependent modulation of NF-kappa B in human T cells.

Authors:  A Bearz; G Tell; A Colombatti; S Formisano; C Pucillo
Journal:  Biochem Biophys Res Commun       Date:  1998-02-24       Impact factor: 3.575

7.  NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.

Authors:  V Heissmeyer; D Krappmann; F G Wulczyn; C Scheidereit
Journal:  EMBO J       Date:  1999-09-01       Impact factor: 11.598

8.  Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).

Authors:  C A Berrevoets; P Doesburg; K Steketee; J Trapman; A O Brinkmann
Journal:  Mol Endocrinol       Date:  1998-08

9.  Orphan receptors, proto-oncogenes and other nuclear factors regulate P450C17 gene transcription.

Authors:  S H Mellon; N A Compagnone; P Zhang
Journal:  Endocr Res       Date:  1998 Aug-Nov       Impact factor: 1.720

10.  Differential effects of tumor necrosis factor-alpha and interleukin-1 on 3 beta-hydroxysteroid dehydrogenase/delta 5-->delta 4 isomerase expression in mouse Leydig cells.

Authors:  Y Xiong; D B Hales
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

View more
  69 in total

1.  Angiopoietin-1 and vascular endothelial growth factor regulation of leukocyte adhesion to endothelial cells: role of nuclear receptor-77.

Authors:  Hodan Ismail; Mahroo Mofarrahi; Raquel Echavarria; Sharon Harel; Eric Verdin; Hyung W Lim; Zheng-Gen Jin; Jianxin Sun; Huiyan Zeng; Sabah N A Hussain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

2.  Anti-steroidogenic factor ARR19 inhibits testicular steroidogenesis through the suppression of Nur77 transactivation.

Authors:  Imteyaz Qamar; Eun-Yeung Gong; Yeawon Kim; Chin-Hee Song; Hyun Joo Lee; Sang-Young Chun; Keesook Lee
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

3.  Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Marjorie McCracken; Eric Vittinghoff
Journal:  Inflamm Bowel Dis       Date:  2011-02-01       Impact factor: 5.325

4.  ARR19 (androgen receptor corepressor of 19 kDa), an antisteroidogenic factor, is regulated by GATA-1 in testicular Leydig cells.

Authors:  Imteyaz Qamar; Eunsook Park; Eun-Yeung Gong; Hyun Joo Lee; Keesook Lee
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

Review 5.  Nuclear receptors and inflammatory diseases.

Authors:  Kun Wang; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2008-03-28

Review 6.  Implications of adiponectin in linking metabolism to testicular function.

Authors:  Luc J Martin
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

7.  HDAC7 modulates TNF-α-mediated suppression of Leydig cell steroidogenesis.

Authors:  Mohanraj Sadasivam; Balamurugan Ramatchandirin; Sivasangari Balakrishnan; Chidambaram Prahalathan
Journal:  Mol Cell Biochem       Date:  2015-04-28       Impact factor: 3.396

8.  Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance.

Authors:  Salama A Salama; Marwa W Kamel; Concepcion R Diaz-Arrastia; Xia Xu; Timothy D Veenstra; Sana Salih; Shaleen K Botting; Raj Kumar
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

9.  Tumor necrosis factor alpha (TNF) suppresses cAMP response element (CRE) activity and nuclear CRE binding protein in MA-10 mouse Leydig tumor cells.

Authors:  Koji Y Arai; Katherine F Roby; Paul F Terranova
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

10.  Insulin directly regulates steroidogenesis via induction of the orphan nuclear receptor DAX-1 in testicular Leydig cells.

Authors:  Seung Won Ahn; Gil-Tae Gang; Yong Deuk Kim; Ryun-Sup Ahn; Robert A Harris; Chul-Ho Lee; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.